NYT > Health: Ranbaxy in $500 Million Settlement of Generic Drug Case

Ranbaxy in $500 Million Settlement of Generic Drug Case

The generic drug maker Ranbaxy pleaded guilty to federal drug safety violations at two of its plants in India and will pay a $500 million fine.

Source: http://www.nytimes.com/2013/05/14/business/global/ranbaxy-in-500-million-settlement-of-generic-drug-case.html?partner=rss&emc=rss